Mistakes and errors in identification and treatment of valvular heart diseases

Česká verzia

Authors: R. Čerbák
Authors place of work: Centrum kardiovaskulární a transplantační chirurgie
Published in the journal: Kardiol Rev Int Med 2009, 11(2): 66-70

Summary

Mistakes and errors in identification and treatment of valvular heart diseases. The information boom of recent years brings the new diagnostic and treatment modalities as well as new mistakes and errors. The prevalence of valvular heart disease increases and their symptomatology changes in response to the aging population. Echocardiography remains the main diagnostic procedure while computer tomography and magnetic resonance represent new opportunities. There are innovations in pharmacological management of valvular heart disease, particularly in the management of the risk factors that facilitate their progression. Surgery moves to earlier stages and preservation surgery is preferred. Despite the advancing knowledge, we still have patients in whom, due to mistakes and errors in diagnosis and treatment, the ideal time for surgery have been missed and this is, in result, the most serious of all mistakes.

Keywords:
valvular heart diseases – symptomatology – diagnosis – treatment of valvular heart diseases – cardiosurgery – mistakes and errors

Zdroje

1. Stollerman GH. Rheumatic fever in the 21st century. Clin Infect Dis 2001; 33: 806–814.

2. Nkomo VT, Gardin JM, Skelton TN et al. Burden of Valvular Heart Disease: A Population‑based study. Lancet 2006; 368: 1005–1011.

3. Sadiq A, Choudhury M, Ali K et al. Echocardiographic characteristic in patients: > or = 100 years of age. Am J Cardiol 2007; 100: 1792–1794.

4. Aschermann M, Widimský P, Veselka J et al. Kardiologie. Praha Galén: 2004.

5. Čerbák R. Mitrální regurgitace 2006 – editorial. Vnitř Lék 2006; 52: 1006–1009.

6. Čerbák R et al. Nejčastější chlopenní vady, aortální stenóza a mitrální regurgitace. Praha: Galén 2007.

7. Čerbák R. EKG změny u aortálních chlopenních vad. Vnitř Lék 2002; 48 Suppl 1: 86–89.

8. Camm AJ, Lüscher TF, Serruys PW. The ESC Textbook of Cardiovascular Medicine. 1st ed. Oxford: Blackwell Publishing 2006.

9. Chockalingam A, Venkatesan S, Subramaniam T et al. Safety and efficacy of angiotensin‑converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). Am Heart J 2004; 147: E19.

10. Gonçalves G, Zornoff LA, Ribeiro HB et al. Blockade of renin‑angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis. Arq Bras Cardiol 2005; 84: 304–308.

11. O’Brien KD, Probstfield JL, Caulfield MT et al. Angiotensin‑converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005; 165: 858–862.

12. Rosenhek R, Rader F, Loho N et al. Statins but not angiotensin‑converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004; 110 : 1291–1295.

13. Linhartová K, Čerbák R, Štěrbáková G. Aortální stenóza a výsledky studie SEAS – má smysl hypolipidemická léčba aortální stenózy? Cor Vasa 2009; 51: 210–211.

14. Popelová J, Benešová M, Brtko M et al. Doporučení pro diagnostiku a léčbu chlopenních srdečních vad v dospělosti. Cor Vasa 2007; 49: K6–K45.

15. Iung B, Baron G, Butchart EG et al. A prospective survey of patiens with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 2003; 24: 1231–1243.

16. Aronow WS, Fleg JL. Cardiovascular Disease in the Elderly. 3rd ed. New York: Marcel Dekker 2004.

17. Adamíra M, Juštík P, Pirk J et al. Náhrada aortální chlopně u nemocných ve věku nad 80 let. Cor et Vasa 2009; v tisku.

18. Dominik J. Kardiochirurgie. Praha: Grada Publishing 1998.

19. Detaint D, Sundt TM, Nkomo VT et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation 2006; 114: 265–272.

20. Cribier A, Eltchaninoff H, Tron C. First human transcatheter implantation of an aortic valve prosthesis in a case of severe calcific aortic stenosis. Ann Cardiol Angeiol 2003; 52: 173–175.

21. Godin M, Tron C, Eltchaninoff H et al. Percutaneous treatment of aortic stenosis. Ann Cardiol Angeiol 2008; 57: 321–326.

22. Želízko M, Janek B, Netuka I et al. Perkutánní implantace aortální chlopně u nemocné s těsnou aortální stenózou. Interv Akut Kardiol 2009; 8: 43–45.

23. Šťásek J, Vojáček J, Bis J et al. První zkušenosti s perkutánní transfemorální implantací chlopně Edwards SapienTM u nemocných s aortální stenózou. Interv Akut Kardiol 2009; 8: 47–51.

24. Dubreuil O, Basmadjian A, Ducharme A et al. Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant. Catheter Cardiovasc Interv 2007; 69: 1053–1061.

25. Feldman T, Wasserman HS, Herrmann HC et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005; 46: 2134–2140.

26. Butchart EG, Gohlke-Bärwolf C, Antunes MJ et al. Recommendation for the management of patients after heart valve surgery. Eur Heart J 2005; 26: 2463–2471.

27. Čerbák R. Collega optimus. Kardiologická revue 2004, 2: 5–6.